Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06688396 · ClinicalTrials.gov registry record · NA
Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
A NA study of Heart Failure and Heart Disease, sponsored by Lancaster General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06688396 is a NA study of Heart Failure and Heart Disease that is actively recruiting participants, run by Lancaster General Hospital. The registered enrollment target is 150 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06688396, a NA study of Heart Failure and Heart Disease, is actively recruiting participants, sponsored by Lancaster General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, single-arm clinical trial in which participants with dilated cardiomyopathy will invite their first degree relatives to undergo mobile cardiac, electrocardiogram screening.
Conditions Studied
Interventions
- DEVICE Mobile 6L AI-EKG Screening
Study Locations (1)
Pennsylvania
- Lancaster General Hospital - Lancaster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-12-04 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06688396
The ClinicalTrials.gov registry entry for NCT06688396 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (93% lower). The listed sponsor is Lancaster General Hospital, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Mobile 6L AI-EKG Screening is the first listed.
NCT06688396 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06688396 about?
NCT06688396 is a clinical study titled "Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)". This is a prospective, single-arm clinical trial in which participants with dilated cardiomyopathy will invite their first degree relatives to undergo mobile cardiac, electrocardiogram screening.
What is the current status of trial NCT06688396?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-12-04. Estimated completion is 2026-12.
What conditions does trial NCT06688396 study?
This clinical trial studies the following conditions: Heart Failure, Heart Disease, Dilated Cardiomyopathy.
What interventions are being tested in trial NCT06688396?
The interventions under investigation include: Mobile 6L AI-EKG Screening (DEVICE).
Who is sponsoring clinical trial NCT06688396?
This trial is sponsored by Lancaster General Hospital, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06688396 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.